Product
CH6001
1 clinical trial
1 indication
Indication
Chronic Obstructive Pulmonary DiseaseClinical trial
Open-label, Non-randomised, Parallel-group Study to Investigate the Pharmacokinetics, Safety and Tolerability Following Single Administration of CHF6001 in Subjects With Mild, Moderate and Severe Renal Impairment in Comparison With Matched Healthy Control SubjectsStatus: Completed, Estimated PCD: 2022-12-27